Jack A. Khattar

President, CEO

Jack A. Khattar (President, CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SUPN. The largest single filing was $1.8M of SUPN (34,880 sh across 2 lots, as filed), executed Mar 13. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.8M

shares × price, as filed

Last traded

Mar 13

Filed Mar 16

Open performance→

Volume by month

Buys $0 Sells $20.0M

Shares × price, as filed · by filing month · past 24 months

Most traded names

SUPN SUPN 0 buys · 13 sells 13 filings

Recent filings

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $2.6M
55,578 sh × $46.01
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $1.6M
34,800 sh across 2 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $5.9M
140,000 sh across 3 lots
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $4.5M
125,000 sh × $36.29
Exec Nov 8 2024
Filed Nov 12 2024 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. View filing → $4.6M
125,000 sh × $36.68
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET